Drugs / FIX
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01440946 | Jun 2012 → Nov 2014 | hemophilia B | Bioverativ Therapeutics Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FIX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01440946 ↗ |
| Route | Intravenous | “participants receive a single intravenous (IV) injection of prestudy FIX and rFIXFc, respectively” NCT01440946 ↗ |